All News

Some recent oncology news includes research into factors impacting the well-being of childhood cancer survivors; whether COVID-19 accommodations will last post-pandemic; and a possible new therapy for patients with polycythemia vera.

Long-term use of prescription sleep medications by middle-aged women provides no benefit, a new study says.

Sandoz Canada launches its sixth biosimilar, an anticoagulant used to treat deep vein thrombosis, on the Canadian market.

Mount Sinai research released today shows a possible link between excess pericardial fat and greater risk of heart failure, with implications for early intervention and prevention of heart disease.

The CDC is looking into rare reports of myocarditis in teens who received a COVID-19 vaccine; reduced air pollution during lockdowns prevented premature deaths; new COVID-19 cases in the United States fall to a 1-year low.

Results from a genome-wide association study indicate blood clot factors may contribute to the cause of migraine with aura.

Here is some of the latest news in diabetes from our sister publication Pharmacy Times®.

There are no curative treatments for Tangier disease, but gene therapy for ABCA1 has been highlighted as a potential avenue for treating the disease, say the researchers of the paper.

Birth control guidance provided to women taking rheumatoid arthritis therapies is lacking, and other rheumatology news reported across MJH Life Sciences™.

A literature review sheds light on cancer risk factors and suboptimal screening levels that persist in the United States among certain racial, ethnic, and socioeconomic groups, despite a steady decline in cancer deaths and smoking prevalence.

With a variety of treatments available for chronic lymphocytic leukemia (CLL), a disease that is extremely heterogeneous, clinicians are faced with a challenging task to choose the right treatment for a patient.

Ultrasounds and MRI are both used to monitor inflammation activity in rheumatoid arthritis, but their value in refining future treatment strategies has so far been unknown.

Posters presented at the ATS 2021 International Conference noted some ways clinical characteristics associated with patients with chronic obstructive pulmonary disease (COPD) differ based on different demographics and smoking status.

Patients with sickle cell disease face substantial health care utilization and impaired health-related quality of life (HRQOL).

Because Medicaid has always been a shared program between federal and state governments, there has been wide variation in income limits. Today, 38 states and the District of Columbia have Medicaid expansion.

Injectable versions of HIV treatments and pre-exposure prophylaxis will be a game changer in terms of convenience over daily pills, noted Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health and director of the Center for Health, Identity, Behavior and Prevention Studies.

The latest coverage in the heart failure space from across MJH Life Sciences™.

A case of a patient with untreated psoriasis and nonischemic dilated cardiomyopathy (NIDCM) prompted clinicians to encourage study of the rare combination of disease.

Researchers say increase in immunotherapy was significant over the study period between 2016 and 2018.

Now that racial and ethnic disparities of atopic dermatitis prevalence among children have been confirmed, the next step in research will be to discover the reasons why those disparities exist, said Jonathan Silverberg, MD, PhD, MPH.

In 2016, long working hours were associated with 745,000 deaths and 23.3 million disability-adjusted life-years from ischemic heart disease and stroke combined.

The World Health Organization’s Covax is feeling the strain from COVID-19 vaccine shortages; Argentina faces a new lockdown following a surge of COVID-19 cases; leronlimab ineffective against COVID-19.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

After switching to 1 of 2 adalimumab biosimilars, patients with inflammatory bowel disease (IBD) experienced comparable clinical outcomes to the reference product after 6 months, according to a recent study.

Joe Zein, MD, PhD, from Cleveland Clinic, explains factors apart from sex and age that can have an impact on a patient's asthma.

Confirmed disability progression is often used as a study endpoint to predict progression, but a new report says its predictive value may be overblown.